Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lentigo maligna
ADR ID BADD_A07356
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
16.03.01      Skin melanomas (excl ocular)
16.03.01.003      Lentigo maligna
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
23.08.01      Skin melanomas (excl ocular)
23.08.01.003      Lentigo maligna
Description A cellular subtype of malignant melanoma. It is a pigmented lesion composed of melanocytes occurring on sun-exposed skin, usually the face and neck. The melanocytes are commonly multinucleated with a "starburst" appearance. It is considered by many to be the in situ phase of lentigo maligna melanoma. [MeSH]
MedDRA Code 10024218
MeSH ID D018327
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hutchinson's melanotic freckle | Hutchison's melanotic freckle | Lentigo maligna | Lentigo maligna melanoma | Lentigo maligna stage unspecified | Melanotic freckle of Hutchinson | Dubreuilh's melanoma | Hutchinson's Melanotic Freckle | Freckle, Hutchinson's Melanotic | Hutchinson Melanotic Freckle | Hutchinsons Melanotic Freckle | Melanotic Freckle, Hutchinson's | Melanotic Freckle | Lentigo, Malignant | Lentigos, Malignant | Malignant Lentigo | Malignant Lentigos | Freckle, Melanotic | Freckles, Melanotic | Melanotic Freckles | Lentigo Maligna
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000362%
BADD_D02018Sildenafil0.000752%
BADD_D02464Fingolimod0.000603%
The 1th Page    1    Total 1 Pages